Sarah Breene

Eli Lilly and Company (London)
Economist

Ms. Breene is a health economist working for Eli Lilly in the UK affiliate. She is responsible for developing strategy and writing HTA submissions for NICE, the Scottish Medicines Consortium and the National Centre for Pharmacoeconomics in Ireland. She has worked for the last two years on achieving market access for new and existing oncology products.

Articles

7843 Bulletin

Send a message